Illinois Court Rules for Defendant in Prenatal Monitoring Patent Dispute
Que souhaitez-vous faire ensuite ?
Choisissez votre parcours en fonction de vos besoins actuels :
📋 Résumé de l'affaire
| Nom de l'affaire | Fitch, Even, Tabin and Flannery, LLP v. Tammy E. Dorsey, James R. Balman, and Prenatal-Hope, Inc. |
| Numéro de dossier | No. 1:25-cv-03141 |
| Tribunal | Northern District of Illinois, Chief Judge Sharon Johnson Coleman |
| Durée | March 25, 2025 – February 23, 2026 335 days |
| Résultat | Defendant Win — No Damages to Plaintiff |
| Brevets en cause | |
| Produits incriminés | Apparatus and method for determining physiological parameters of an infant in utero |
Aperçu du dossier
Les parties
⚖️ Demandeur
A prominent Chicago-based intellectual property law firm, acting as plaintiff, signaling a direct IP ownership or enforcement interest.
🛡️ Défendeur
The accused parties in this dispute, with Prenatal-Hope, Inc. likely operating in the prenatal diagnostics or monitoring space.
Brevets en cause
This case centered on U.S. Patent No. US11622705B2, covering an apparatus and method for determining physiological parameters of an infant in utero — a critical technology in the growing market for non-invasive fetal health assessment.
- • US11622705B2 — Apparatus and method for determining physiological parameters of an infant in utero
Designing a prenatal monitoring device?
Check if your technology might infringe this or related patents before launch.
Le verdict et l'analyse juridique
Résultat
The court entered a verdict in favor of defendants Tammy E. Dorsey, James R. Balman, and Prenatal-Hope, Inc., and against plaintiff Fitch, Even, Tabin and Flannery, LLP. No damages award to plaintiff was recorded, making this a significant defendant-favorable outcome in medical device patent litigation.
Principales questions juridiques
While the specific legal reasoning is undisclosed, a defendant-favorable outcome in a patent infringement action can arise from several pathways: a finding of non-infringement, successful challenges to patent invalidity (e.g., due to obviousness or anticipation), or a claim construction adverse to the plaintiff’s assertions. For medical device method patents, the precise scope of functional claim language often proves dispositive.
Freedom to Operate (FTO) Analysis in Prenatal Monitoring
This case highlights critical IP risks in the rapidly evolving prenatal monitoring space. Choose your next step:
📋 Comprendre l'impact de cette affaire
Découvrez les risques et les implications spécifiques liés à ce litige.
- View all 65 related patents in this technology space
- See which companies are most active in prenatal monitoring IP
- Understand claim construction patterns for physiological measurement
🔍 Vérifier les risques liés à mon produit
Effectuez une analyse FTO complète pour votre propre technologie ou produit.
- Saisissez la description de votre produit ou ses caractéristiques techniques.
- L'IA identifie les brevets susceptibles de constituer un obstacle
- Obtenir un rapport d'évaluation des risques exploitable
Zone à haut risque
In-utero physiological monitoring methods
65 Related Patents
In prenatal health tech space
Options de contournement
Disponible pour la plupart des interprétations de demandes d'indemnisation
✅ Points clés à retenir
Defendant prevailed in a medical device method patent (US11622705B2) infringement action in N.D. Illinois within 335 days, suggesting a potentially early dispositive resolution.
Rechercher la jurisprudence connexe →Claim construction for physiological monitoring method claims remains a critical battleground, impacting both infringement and validity.
Explorer les précédents →Foire aux questions
The case involved U.S. Patent No. US11622705B2 (Application No. US17/555256), covering an apparatus and method for determining physiological parameters of an infant in utero.
The Northern District of Illinois ruled in favor of defendants Tammy E. Dorsey, James R. Balman, and Prenatal-Hope, Inc., and against plaintiff Fitch, Even, Tabin and Flannery, LLP in this infringement action.
The outcome may embolden defendants in similar cases to mount stronger invalidity and non-infringement defenses, and signals that courts will rigorously apply claim construction standards to physiological monitoring method patents.
The case was resolved within approximately 335 days from filing to closure, which is significantly faster than the national median for patent litigation at the district court level, typically exceeding 18-24 months.
Prêt à renforcer votre stratégie en matière de brevets ?
Rejoignez plus de 18 000 professionnels de la propriété intellectuelle qui utilisent PatSnap Eureka pour effectuer des recherches d'antériorité, rédiger des brevets et analyser le paysage concurrentiel avec une précision optimisée par l'IA.
Références
- U.S. District Court for the Northern District of Illinois — Case No. 1:25-cv-03141
- U.S. Patent and Trademark Office — Patent Full-Text Database (US11622705B2)
- Cornell Legal Information Institute — 35 U.S.C. § 103 (Obviousness)
- Federal Judiciary CMECF System — Accessing Court Records
- PatSnap — IP Intelligence Solutions for Medical Devices
Cet article est publié à titre purement informatif et ne constitue en aucun cas un avis juridique. Toutes les informations relatives aux affaires sont tirées de dossiers judiciaires accessibles au public. Pour en savoir plus sur les fonctionnalités de la plateforme, rendez-vous sur PatSnap.